The indication for the prolonged release melatonin product Circadin has been extended to up to 13 weeks in patients with primary insomnia.
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
Followers
Blog Archive
-
▼
2011
(69)
-
▼
May
(8)
- A third of nurse whistleblowers are ignored, shows...
- Nurses win awards for hard work
- Frontline staffing cuts drive up nurse sickness ra...
- NICE to consult on childhood constipation guidelines
- Sturgeon admits locum situation is now a problem -...
- Drug reduces alcoholism relapses
- Insomnia treatment approved for longer use
- Royal society calls for alcohol liaison officer in...
-
▼
May
(8)
No comments:
Post a Comment